Akèy › Maladi Parkinson › Michigan
Etid klinik pou Maladi Parkinson nan Michigan
21 etid pou Maladi Parkinson ap chèche patisipan nan sit nan Michigan.
Vil nan Michigan
Tèks ofisyèl etid la (Anglè)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Quest Research Institute, Farmington Hills
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06680830A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- Quest Research Institute - Alcanza, Farmington Hills
Ap rekriteFaz 1Volontè an sante akeyi
Laj 30 a 80 · Tout sèks · Mizajou Oct 1, 2026 · NCT06565195A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-015, Farmington Hills
Ap rekriteFaz 2/3
Laj 40 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT06976268A Study of Buntanetap in Participants With PD
- Quest Research Institute, Farmington Hills
Ap rekriteFaz 2/3
Laj 40 a 85 · Tout sèks · Mizajou Sep 21, 2026 · NCT07284784Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- University of Michigan, Ann Arbor
- Michigan State University, East Lansing
- Quest Research Institute, Farmington Hills
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07005180A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #002, Farmington Hills
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- University of Michigan Health System (UMHS) (Site #202), Ann Arbor
- Quest Research Institute - Alcanza - PPDS (Site #201), Farmington Hills
Ap rekriteFaz 2
Laj 30 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07432958A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
- Quest Research Institute - Alcanza - HyperCore - PPDS, Farmington Hills
Ap rekriteFaz 2
Laj 40 a 85 · Tout sèks · Mizajou Sep 8, 2026 · NCT07514858A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- University of Michigan, Ann Arbor
Ap rekriteEtid obsèvasyon
Laj 45 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07330258A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Quest Research Institute, Farmington Hills
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 3, 2026 · NCT07174310A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
- Domino's Farms, Ann Arbor
Ap rekriteFaz 1
Laj 50 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT07543861A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Michigan Clinical Research Unit - Neurology, Ann Arbor
- University of Michigan Clinical Research Unit - Neurology, Ann Arbor
- Quest Research Institute, Farmington Hills
Ap rekriteFaz 3
Laj 45 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Michigan, Ann Arbor
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
- University of Michigan, Ann Arbor
Ap rekriteEtid obsèvasyon
Laj 45 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT07642908Natural History Study of Synucleinopathies
- University of Michigan, Ann Arbor
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT01799915SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Quest Research Institute, Farmington Hills
Ap rekriteFaz 1
Laj 40 a 80 · Tout sèks · Mizajou Jun 5, 2026 · NCT07422675Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
- Michigan State University, East Lansing
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT07599696A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- QUEST Research Institute, Farmington Hills
Ap rekriteFaz 1Volontè an sante akeyi
Laj 30 a 85 · Tout sèks · Mizajou Apr 20, 2026 · NCT06809400Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
- University of Michigan, Ann Arbor
Ap rekriteFaz 2
Laj 45 ak plis · Tout sèks · Mizajou Mar 31, 2026 · NCT06679374Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Domino's Farms, Ann Arbor
Ap rekriteFaz 1/2
Laj 45 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT07154511A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Quest Research Institute, Farmington Hills
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2025 · NCT06765668Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.